Atherosclerosis
898
63
89
572
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
98 trials with published results (11%)
Research Maturity
572 completed trials (64% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
53 terminated out of 898 trials
91.5%
+5.0% vs benchmark
19%
171 trials in Phase 3/4
17%
98 of 572 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 572 completed trials
Clinical Trials (898)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
New Heart Imaging Techniques to Evaluate Possible Heart Disease
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY
Causes and Natural History of Dyslipidemias
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
DETECTion of the Prevalence of Silent Atherosclerosis Across Adult Life - Phase I of REACT
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Senescence in Myocardial Infarction
Strategy for Unstable Coronary Plaque in Patients Presenting to Emergency Department for Chest Pain Suspected of Coronary Artery Disease
Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis.
Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)
Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study